Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey

Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expenditures Panel Survey

BackgroundAtherosclerotic cardiovascular disease (ASCVD) causes most deaths in the United States and accounts for the highest healthcare spending. The association between the modifiable risk factors (MRFs) of ASCVD and pharmaceutical expenditures are largely unknown. Methods and ResultsWe examined t...

Full description

Bibliographic Details
Main Authors: Joseph A. Salami, Javier Valero‐Elizondo, Oluseye Ogunmoroti, Erica S. Spatz, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Adnan Younus, Alejandro Arrieta, Michael J. Blaha, Emir Veledar, Khurram Nasir
Format: Article
Language:English
Published: Wiley 2017-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
coronary heart disease
cost
modifiable risk factors
pharmaceutical expenditure
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.004996

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.004996

Similar Items